Gold is 2025’s best performer. UBS sees more upside
Investing.com -- Kenvue Inc (NYSE:KVUE) stock jumped 5.3% after the consumer health company announced a CEO transition and ongoing strategic review aimed at unlocking shareholder value.
The company said its Board of Directors has appointed Kirk Perry as Interim Chief Executive Officer, effective immediately, replacing Thibaut Mongon who has departed the company and stepped down from the Board. Perry, a current Kenvue director, brings over 30 years of experience in consumer packaged goods, technology, and business transformation.
Alongside the leadership change, Kenvue revealed that its Board had previously initiated a comprehensive review of strategic alternatives and established a Strategic Review Committee. The review will consider various options, including optimizing the company’s brand portfolio, while improving execution and enhancing operating performance.
"We expect a positive reaction today to the news," said Citi analyst Filippo Falorni, who maintained a Neutral rating and $24.50 price target on Kenvue.
Kenvue Chair Larry Merlo emphasized the company’s "world-class brands in attractive categories and strong global platform," noting that the announced actions aim to "ensure we have the right talent, brand portfolio and operational foundation" to accelerate profitable growth.
The company plans to report full second-quarter financial results on August 7, when it will also revise its full-year 2025 outlook. Kenvue’s strategic review is being advised by Centerview Partners and McKinsey & Company.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.